Article
A novel germline hyperactivating JAK2 mutation L604F.
Annals of hematology - 1 Oct 2023
Dvořáček Lukáš, Marková Jana, Holoubek Aleš, Grebeňová Dana, Kundrát David, Kuželová Kateřina, Schwarz Jiří
Abstract excerpt
Somatic JAK2 mutations are the main molecular cause of the vast majority of polycythemia vera (PV) cases. According to a recent structural model, the prevalent acquired V617F mutation improves the stability of the JAK2 dimer, thereby enhancing the constitutive JAK2 kinase activity. Germline JAK2 mutations usually do not largely alter JAK2 signaling, although they may modulate the impact of V617F. We found an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
